COCRYSTAL PHARMA, INC. Accumulated Other Comprehensive Income
COCRYSTAL PHARMA, INC. (COCP) had Accumulated Other Comprehensive Income of $0 as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2016-05-10
- 2016-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2015-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2015-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$744.00K.
- 2014-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $236.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-10 |
| 2015-03-31 | -$744.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $236.00K 10-Q · filed 2015-11-16 |
| 2014-09-30 | $2.23M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $1.83M 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$1.45M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |